ArticleOncotarget2015

The TLR7 agonist induces tumor regression both by promoting CD4⁺T cells proliferation and by reversing T regulatory cell-mediated suppression via dendritic cells.

Chenchen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.